{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-21-005354","form_type":"8-K","ticker":"PAYS","cik":"0001496443","company_name":"Paysign, Inc.","filed_at":"2021-11-09T23:59:59+00:00","discovered_at":"2026-05-14T18:04:12.747586+00:00","generated_at":"2026-06-28T10:37:53.610088+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Paysign Q3 revenue $7.8M; plasma $7.0M (+35.6% YoY); net loss $0.3M; raises adj. EBITDA guidance to $1.3-1.9M","bullets":["Total revenue $7.8M for Q3 2021, up $1.1M (16.8%) from Q2 2021 and $7.9M from year-ago.","Plasma revenue $7.0M (+35.6% YoY); added 3 plasma centers for a total of 359.","Net loss of $0.3M ($0.01 per diluted share) compared to net loss of $6.2M in Q3 2020.","Adjusted EBITDA $1.0M ($0.02 per share) vs. $0.3M loss a year ago; FY forecast raised to $1.3-1.9M.","Gross profit margin guidance raised 250 bps to 49.0% for full year 2021."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-21-005354","json":"https://secwatch.observer/filing/0001683168-21-005354.json","markdown":"https://secwatch.observer/filing/0001683168-21-005354.md","text":"https://secwatch.observer/filing/0001683168-21-005354.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1496443/000168316821005354/0001683168-21-005354-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1496443/000168316821005354/paysign_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T10:37:53.610088+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}